Tillement Jp
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Protein Interaction Studies and Fluorescence Analysis 4
-
- Pharmaceutical studies and practices 9
- Pharmacological Effects and Toxicity Studies 7
- Co-authors
- E Albengres (20 shared papers)Roland Zini (9 shared papers)J. Barré (9 shared papers)Boissier (11 shared papers)Françoise Brée (8 shared papers)Saı̈k Urien (6 shared papers)Georges Houin (7 shared papers)Didier Morin (4 shared papers)
- Journals
- Journal of Pharmacy and Pharmacology (2 papers)Fundamental and Clinical Pharmacology (2 papers)PubMed (68 papers)
- Partner nations
- France
In The Last Decade
Tillement Jp
68 papers receiving 355 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 69
- Pharmacology 60
- Behavioral Neuroscience 9
- Clinical Biochemistry 16
- Complementary and alternative medicine 18
Countries citing papers authored by Tillement Jp
This map shows the geographic impact of Tillement Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tillement Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tillement Jp more than expected).
Fields of papers citing papers by Tillement Jp
This network shows the impact of papers produced by Tillement Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tillement Jp. The network helps show where Tillement Jp may publish in the future.
Co-authors
The 25 scholars most cited alongside Tillement Jp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 26 | |
| 2 | In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs. | 1986 | 22 |
| 3 | Disease-induced modifications of drug pharmacokinetics. | 1983 | 20 |
| 4 | Effect of Ginkgo biloba extract on microsomal enzyme induction. | 1989 | 19 |
| 5 | Serum protein binding of valproic acid in healthy subjects and in patients with liver disease. | 1981 | 19 |
| 6 | [Action of some psychotropic substances on mice in a free state subjected to an exteroceptive stimulus]. | 1969 | 18 |
| 7 | Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population. | 1993 | 17 |
| 8 | The pharmacokinetics and availability of niflumic acid in humans. | 1983 | 14 |
| 9 | Inhibition of rat cerebral mitochondrial respiration by cyclosporins A, D, and G and restoration with trimetazidine. | 1996 | 12 |
| 10 | Clofibrate and enzymatic induction in man. | 1978 | 10 |
| 11 | Comparative study of bepridil and nicardipine action on respiration and calcium transport in mitochondria. | 1987 | 10 |
| 12 | [Severe hyponatremia after repeated administration of terlipressin]. | 1994 | 9 |
| 13 | Cyclic AMP and inositol phosphate accumulations in rat brain cortical slices following chronic citalopram or desipramine administration. | 1994 | 8 |
| 14 | Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein. | 1983 | 8 |
| 15 | [Metabolism of niflumic acid in man]. | 1971 | 8 |
| 16 | In vitro study of the binding of RU 486 and RU 42 633 to human serum proteins. | 1989 | 7 |
| 17 | Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors. | 1987 | 7 |
| 18 | 1991 | 6 | |
| 19 | Comparison of drug binding capacities of two AAG peptidic variants of human origin. | 1989 | 6 |
| 20 | [Pharmacological approach to the rational use of cardiotonic heterosides]. | 1977 | 5 |
About Tillement Jp
Tillement Jp is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Clinical Biochemistry, Pharmacology and Biochemistry, having authored 72 papers that have together received 384 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (12 papers), Pharmaceutical studies and practices (9 papers), Pharmacological Effects and Toxicity Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Amino Acid Enzymes and Metabolism (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Protein Interaction Studies and Fluorescence Analysis (4 papers). The work is most often cited by research in Pharmacology (69 citations), Pharmacology (60 citations), Behavioral Neuroscience (9 citations), Clinical Biochemistry (16 citations) and Complementary and alternative medicine (18 citations). Tillement Jp has collaborated with scholars based in France. Frequent co-authors include E Albengres, Roland Zini, J. Barré, Boissier, Françoise Brée, Saı̈k Urien, Georges Houin, Didier Morin, A. Crevat and C.‐A. Hamberger. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Fundamental and Clinical Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.